Incanthera (AQSE:INC) Total Tax Payable : £0.00 Mil (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Incanthera Total Tax Payable?

Incanthera's Total Tax Payable for the quarter that ended in Sep. 2023 was £0.00 Mil.

Incanthera's quarterly Total Tax Payable increased from Sep. 2022 (£0.00 Mil) to Mar. 2023 (£0.00 Mil) but then declined from Mar. 2023 (£0.00 Mil) to Sep. 2023 (£0.00 Mil).

Incanthera's annual Total Tax Payable declined from Mar. 2021 (£0.03 Mil) to Mar. 2022 (£0.01 Mil) and declined from Mar. 2022 (£0.01 Mil) to Mar. 2023 (£0.00 Mil).

Incanthera Total Tax Payable Historical Data

The historical data trend for Incanthera's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Total Tax Payable Chart

Incanthera Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Total Tax Payable

0.03

0.01

Incanthera Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Total Tax Payable	Get a 7-Day Free Trial			-	0.01	-	-	-

Incanthera Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Incanthera Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Incanthera's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera (AQSE:INC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

76 King Street, Manchester, GBR, M2 4NH

Website

http://www.incanthera.com

Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines